Clint Narver Partner

In his role at the DOJ, Clint was instrumental in overseeing complex, high-profile investigations and prosecutions involving drugs, medical devices, biologics, food, dietary supplements, tobacco products, clinical research, drug supply chain integrity, counterfeiting, grant fraud, and healthcare fraud. His work ensured compliance with FDA regulations and protected public health by holding corporations and individuals accountable for violations of the FDCA and related statutes, including the False Claims Act, the Anti-Kickback statute, the Safe Doses Act, the Consumer Product Safety Act, and numerous fraud and customs laws. Clint’s deep understanding of the regulatory landscape and enforcement priorities makes him a valuable asset to clients navigating the complexities of FDA and broader healthcare industry compliance. Clint also previously served as a trial attorney at DOJ’s Consumer Protection Branch, where he led investigations and prosecutions aimed at ensuring the safety and efficacy of FDA-regulated products and combating complex consumer fraud schemes.

Before his tenure at the DOJ, Clint served in various capacities with the FDA’s Office of the Chief Counsel, where he developed a keen insight into the agency’s inner workings and regulatory processes. While with the FDA, Clint supported the agency’s Health Care Fraud and Abuse Control (HCFAC) program and worked closely with the Center for Drug Evaluation and Research, the Center for Devices and Radiological Health, and the Office of Criminal Investigations, among other FDA components. Clint also served as a Special Assistant U.S. Attorney in multiple jurisdictions, litigating cases at both the trial and appellate levels. This dual experience at both the DOJ and FDA provides him with a unique perspective on the interplay between regulatory compliance and enforcement actions.

At McGuireWoods, Clint advises clients—including those in the pharmaceutical, biotechnology, medical device, and food industries—on a wide range of FDA-related matters. Among other things, he counsels clients on FDA inspections, warning letters, labeling and advertising issues, product recalls, clinical trial compliance, and FDA-related enforcement issues, including product seizures, injunctions, consent decrees, and civil money penalties. Clint also defends companies and individuals facing DOJ, state, and other government investigations and enforcement actions, assists clients with compliance audits and internal investigations, and helps clients establish effective corporate compliance programs.

Clint’s background as a federal enforcement official and his hands-on experience with FDA regulatory issues enable him to provide strategic, practical advice to clients facing regulatory challenges. His proactive approach helps clients anticipate and address potential issues before they escalate, ensuring compliance and minimizing risk.